by Julie Fine, BS, Legal Specialist, Worldwide Research and Development, Pfizer Inc, La Jolla, California
In the many months that have passed since the 2013 Advancing Ethical Research Conference, I’ve been reflecting on the keynote speeches, the sessions I attended, and the incredible retirement luncheon celebrating Joan Rachlin’s outstanding leadership of PRIM&R. Recently, my Pfizer colleagues and I had an opportunity to share highlights from our experiences with members of our legal organization, giving them the benefit of some of what we learned. We talked about data sharing, “best medical care” vs. “research,” and academic-industry partnerships.* It was a good opportunity for us to bring research ethics conversations to the fore and share some of the insights we gained from attendance at the conference.
But it was a chance meeting on the final day of the conference that has really stuck with me. On the Saturday morning of the conference, I went to grab coffee and breakfast with a friend of mine. We picked a quiet table where only one other person was sitting. The woman at the table was Inge Auerbacher, who was at the conference to present her documentary film, Finding Dr. Schatz: The Discovery of Streptomycin and a Life It Saved. The three of us chatted, and I quickly became enthralled by Inge’s curiosity and intelligence.
Later that day, I attended Inge’s presentation of her documentary, and I discovered that the charming, articulate woman that I had shared breakfast with had survived the Holocaust and overcome tuberculosis to become a respected scientist and author.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.